Core Viewpoint - Strong Brain Technology is set to achieve its first profitable year in 2025, with significant revenue contributions from products aimed at the mass consumer market [4][17]. Group 1: Company Overview - Strong Brain Technology, founded by Han Bicheng in 2015, operates offices in Hangzhou, Shenzhen, and the US (Boston and Austin), with a peak employee count of around 300-400 [9]. - The company has recently gained attention due to favorable market conditions, including the influence of Musk and supportive domestic policies, positioning it prominently among the "Hangzhou Six Dragons" [9][31]. - In January 2026, Strong Brain completed a record-breaking financing round of 2 billion yuan, the largest single financing in the "Six Dragons" group, and has secretly applied for an IPO in Hong Kong [10][20]. Group 2: Product Lines and Market Strategy - Strong Brain has three main product lines: intelligent bionic series (prosthetics), intelligent health series (sleep aids, attention training), and intelligent education [20]. - The company’s bionic hands can be priced at tens of thousands of dollars in overseas markets, contributing nearly half of its total revenue, while domestic products are offered at significantly lower prices to accommodate local purchasing power [23]. - The company’s consumer products include a wearable brainwave device and a smart sleep aid, which have gained popularity despite some controversy regarding their effectiveness and privacy concerns [24][26]. Group 3: Industry Context and Competition - The brain-computer interface (BCI) sector is experiencing rapid growth, with 16 financing events in 2025 totaling 983 million yuan, a nearly fourfold increase from 2024 [16]. - Strong Brain's approach focuses on non-invasive technology, which is seen as a more practical and commercially viable path compared to invasive methods [20]. - The global competition in the BCI field is intensifying, with significant developments from companies like Neuralink, which is expected to start large-scale production of BCI devices in 2026 [34][35]. Group 4: Future Aspirations and Challenges - Strong Brain aims to help 1 million disabled individuals regain mobility and reintegrate into society within the next five to ten years, supported by its recent funding for core technology development and product scaling [31]. - Despite the promising outlook, the BCI industry faces challenges such as technological breakthroughs, ethical reviews, and the construction of commercial closed loops, which could hinder progress [36].

Core Viewpoint - In 2025, China's GDP surpassed 140 trillion yuan, achieving a 5% growth compared to the previous year, marking a significant milestone in the country's economic development and laying a solid foundation for future growth [1][2]. Economic Performance - The GDP reached 140,187.9 billion yuan, with a stable urban unemployment rate averaging 5.2% and record high goods trade, alongside foreign exchange reserves exceeding 3.3 trillion USD [2]. - The contribution of final consumption expenditure to economic growth exceeded 50%, indicating a shift towards a consumption-driven economy [2]. - The added value of high-tech manufacturing accounted for 17.1% of the total industrial output, reflecting a structural optimization in the economy [2]. Innovation and Development - R&D expenditure intensity reached 2.8%, surpassing the OECD average for the first time, and China's innovation index entered the global top ten [3]. - The economy demonstrated resilience and quality improvement, with a significant contribution to global economic growth, estimated at around 30% [3][5]. Economic Stability and Growth - The continuous increase in GDP during the "14th Five-Year Plan" period reflects a robust economic foundation and enhanced risk resistance [4]. - The service sector's contribution to GDP rose to 57.7%, and the manufacturing sector maintained its position as the world's largest for 16 consecutive years [4]. Global Economic Contribution - China's average contribution to global economic growth during the "14th Five-Year Plan" period was approximately 30%, providing stability and cooperation opportunities for the world economy [5]. Future Outlook - The year 2026 marks the beginning of the "15th Five-Year Plan," with a focus on leveraging opportunities despite external challenges, supported by a solid economic foundation and ongoing reforms [6][7]. - The implementation of proactive macroeconomic policies is expected to ensure stable economic performance in the face of complex environments [7].

Economic Policy and Market Outlook - Recent economic policies, including structural interest rate cuts, are expected to support economic growth, potentially leading to a "good start" in the first quarter of 2026, although final performance will depend on forthcoming data [5] - The financial market policies have moderated previously overheated sectors, indicating that the market may not sustain its rapid upward trend and could transition into a more volatile phase [5] Fund Market Trends - The Hong Kong stock market saw an overall increase, while domestic equity markets experienced fluctuations; TMT-themed funds performed well, whereas defense and military-themed funds faced net value declines [5] - There was a notable reduction in passive fund holdings across various broad-based ETFs, with over 130 billion yuan flowing out of large-cap ETFs, while TMT and cyclical theme ETFs attracted over 60 billion yuan in net inflows [5] Economic Data Insights - The economic landscape in 2025 is characterized by a "high before low" trend, with supply outpacing demand and external demand exceeding internal demand [6] - In December 2025, industrial production growth rates increased year-on-year and month-on-month, while fixed asset investment saw a widening decline, and retail sales growth continued to decrease [6] Oil and Geopolitical Factors - Heightened geopolitical tensions in Iran have increased the geopolitical risk premium on oil, contributing to rising oil prices; as of January 16, 2026, Brent and WTI crude oil prices were reported at $64.20 and $59.22 per barrel, reflecting increases of 1.9% and 0.7% respectively [7] - The ongoing international instability is likely to provide a favorable foundation for oil price trends in the long term [7] Infrastructure Investment - The State Grid has announced a planned fixed asset investment of 4 trillion yuan during the 14th Five-Year Plan period, marking a 40% increase compared to the previous plan, focusing on power grid and energy storage sectors [8] - Key projects for 2026 will concentrate on ultra-high voltage and pumped storage, indicating potential opportunities in power infrastructure orders and renewable energy consumption [8] Power Consumption and Digitalization - In 2025, the total electricity consumption in society increased by 5.0% year-on-year [9] - The State Grid's investment in new power systems is expected to enhance capacity pricing, with projected capacity prices for 2026 estimated at 6.3 cents per kilowatt-hour, a 4-cent increase from the previous year [9] Pharmaceutical Sector Innovations - The pharmaceutical and biotechnology sectors are experiencing a surge driven by innovation, including overseas expansion, AI applications, and new technologies, alongside policy support and seasonal market dynamics [9] - Key focus areas include innovative drugs, CXO services, AI healthcare, brain-computer interfaces, and small nucleic acid drugs, with ongoing attention required on post-JPM conference collaborations and clinical data outcomes [9]

Market Overview - The A-share pharmaceutical and biotechnology index fell by 0.68%, underperforming the CSI 300 index by 0.11 percentage points and the ChiNext index by 1.97 percentage points, ranking 19th among 31 sub-industries [4] - The Hong Kong Hang Seng Healthcare Index rose by 2.38%, outperforming the Hang Seng China Enterprises Index by 0.48 percentage points [4] R&D Progress - Last week, Qinhai Pharmaceutical's GH55 and Innovent Biologics' IBI343 clinical applications were newly undertaken [5] - Sangfor's 608 is currently in Phase III clinical trials; Aosaikang's ASK092 is in Phase II; and Hansoh Pharmaceutical's HS-20093 is in Phase I clinical trials [5] Industry Insights - The pharmaceutical and biotechnology sector is driven by innovation (including overseas expansion, AI, and new technologies), performance validation, policy benefits, and seasonal market movements, with a focus on innovative drugs and CXO in the short term [6] - AI in healthcare and pharmaceuticals, brain-computer interfaces, and small nucleic acid drugs are identified as high-potential sub-themes [6] - Continuous attention is required on the outcomes of collaborations post-JPM conference, clinical data of innovative drugs, and performance realization [6] Investment Strategy for 2026 - The investment focus in the pharmaceutical sector should increasingly emphasize the clinical value logic, addressing clinical needs of patients and doctors, influenced by domestic medical insurance policies and global expansion [7] - The clinical value is expected to command higher premiums, leading to a favorable outlook on the innovative drug supply chain and innovative medical devices [7]

Group 1 - OpenAI's annual recurring revenue (ARR) is expected to exceed $20 billion by 2025, with a computing power scale of 1.9GW, achieving a tenfold revenue growth and 9.5 times increase in computing power within three years [2] - Micron Technology is acquiring the P5 wafer fab from Powerchip Semiconductor for $1.8 billion, expected to complete in Q2 2026, which will enhance Micron's position in the global DRAM market amid increasing demand from AI infrastructure [2] - Tesla's Neuralink has made advancements in brain-machine interface technology, allowing upgrades without surgery, and plans to restart the Dojo 3 supercomputer project, with a new affordable Model 3/Y targeting the Chinese market [3] Group 2 - Apple is set to regain the top position in the Chinese smartphone market with a 28% year-on-year increase in iPhone shipments by Q4 2025, and is developing the iPhone 18 Pro series with advanced features [3] - Baiwei Storage expects a net profit of 850 million to 1 billion yuan in 2025, representing a year-on-year growth of 427.19% to 520.22% [4] - China Duty Free Group plans to acquire DFS's travel retail business in Greater China for up to $395 million, strengthening its market position [6] Group 3 - Pfizer's CEO indicated that the company may raise drug prices abroad due to a pricing agreement with former President Trump, which could lead to a halt in new drug supplies to Europe if price increases are rejected [9] - Toyota aims for over 1.78 million vehicle sales in China by 2025, collaborating with Fujitsu to simplify automotive ECU design using quantum-inspired technology [11] - LVMH's DFS Group is selling its Greater China retail business to China Duty Free Group for up to $395 million, indicating significant market movements in the luxury retail sector [13]

Core Insights - OpenAI's investment in Merge Labs signals a competitive shift towards brain-computer interface (BCI) technology, indicating it may become a central focus in the next tech race [1][6] - The BCI market is projected to grow significantly, with estimates suggesting it could exceed $10 billion by 2030 [10] Investment and Company Developments - Merge Labs has raised $252 million in funding, led by Bain Capital, with OpenAI as the largest investor, bringing its valuation to $850 million [3][4] - The company aims to develop non-invasive BCI technologies that connect humans and AI without the need for surgical implants [4][9] Competitive Landscape - The competition between OpenAI and Neuralink, founded by Elon Musk, highlights a personal rivalry that may elevate public interest in the BCI sector [4][7] - Other startups like Paradromics, Precision Neuroscience, and Synchron are also actively developing BCI technologies, indicating a broader competitive environment beyond just two companies [7] Technological Implications - AI is expected to enhance BCI development by enabling systems that can understand user intent and operate reliably, potentially making Merge Labs a key player in integrating AI with BCI [5][9] - Current BCI technologies allow paralyzed patients to control devices, but future advancements could enable more complex tasks, marking a significant technological paradigm shift [8] Market Trends and Future Outlook - The global BCI market is anticipated to reach approximately $1.27 billion by 2025, with significant investments already made in both invasive and non-invasive technologies [10][14] - China's rapid development in the BCI field, supported by government initiatives, positions it as a strong competitor to the U.S., particularly in non-invasive applications [12][13]

Core Viewpoint - The 2026 Future Industries New Materials Expo (FINE 2026) aims to lead global innovation in new materials, emphasizing their critical role in the transformation of high-tech industries and the future economy [1][2]. Group 1: Event Overview - FINE 2026 will take place from June 10 to June 12, 2026, at the Shanghai New International Expo Center, featuring a total exhibition area of 50,000 square meters and over 800 exhibitors [12][34]. - The expo will include more than 300 strategic and cutting-edge technology reports, showcasing innovations applicable to various industries such as AI, aerospace, smart vehicles, and renewable energy [2][20]. Group 2: Focus Areas - The event will focus on five common needs of future industries: advanced semiconductors, advanced batteries, lightweight functional materials, low-carbon sustainability, and thermal management [2][10]. - Six thematic exhibition areas will be established, including advanced semiconductors, advanced batteries and energy materials, thermal management, lightweight and sustainable materials, new materials technology innovation, and future smart terminals [12][15]. Group 3: Participation and Audience - FINE 2026 is expected to attract over 100,000 professional visitors, including industry leaders and investors, facilitating precise connections between enterprises and industry resources [34][35]. - The event will invite over 5,000 industry investors to support quality startups and enhance collaboration opportunities [10][35]. Group 4: Supporting Organizations - The expo is organized by DT New Materials, in collaboration with various associations and institutions, including the China Productivity Promotion Center and the Ningbo New Materials Industry Association [4][5]. - The event will also feature participation from numerous well-known companies and investment institutions, enhancing its credibility and outreach [35][37]. Group 5: Historical Context and Expectations - FINE 2026 builds on the success of previous expos, including the 2025 International Carbon Materials Expo and the 2025 Thermal Management Expo, which collectively attracted over 35,000 professional visitors from 27 countries [7][34]. - The event is positioned as a pivotal opportunity for businesses to engage in technology transfer and innovation in the new materials sector, aiming to solidify China's position in the global high-tech industry [2][10].

Core Insights - China's economy has surpassed 140 trillion yuan, with a GDP growth of 5.0% year-on-year, contributing approximately 30% to global economic growth [1][2] - The achievement of crossing the 140 trillion yuan mark reflects China's resilience and ability to adapt to complex international conditions, providing certainty and new opportunities for the global economy [1][3] Economic Performance - In the "14th Five-Year Plan" period, China's economy has consistently crossed significant thresholds: 110 trillion, 120 trillion, 130 trillion, and now 140 trillion yuan, showcasing its robust growth [1] - The manufacturing value added in the digital product sector increased by 9.3% year-on-year, indicating strong growth in advanced technology sectors [2] Innovation and Development - By 2025, China's R&D expenditure intensity is expected to reach 2.8%, surpassing the OECD average for the first time, highlighting a commitment to innovation [2] - Significant advancements in cutting-edge fields such as artificial intelligence, quantum technology, and brain-computer interfaces are emerging, contributing to new productive forces [2] Trade and Openness - The Hainan Free Trade Port has commenced full island closure operations, with total import and export volume increasing by 3.8%, demonstrating China's commitment to maintaining open trade despite global protectionism [3] - China's per capita disposable income grew by 5.0%, aligning with economic growth, and improvements in social welfare sectors such as elderly care and healthcare are evident [3] Future Outlook - The upcoming "15th Five-Year Plan" outlines ambitious goals for China's economic and social development, presenting a "list of opportunities" for global collaboration [3] - China's focus on high-quality development and high-level openness is expected to inject more certainty and new momentum into the global economy, fostering shared growth [3]

2025年中国经济成绩单揭晓，经济总量突破140万亿元！国家统计局数据显示，初步核算，全年国内生 产总值1401879亿元，按不变价格计算，比上年增长5%。 "这一年，我国发展历程很不平凡，取得的成绩令人鼓舞，经济顶压前行、向新向优发展，主要预期目 标圆满实现，'十四五'胜利收官，第二个百年奋斗目标新征程实现良好开局。"1月19日，国家统计局局 长康义在国新办发布会上表示。 增长5%成色如何 "稳"的格局得到巩固。面对外部环境急剧变化、国内困难挑战增多的复杂严峻形势，我国实施更加积极 有为的宏观政策，不仅有效化解外部环境变化的不利影响，更稳住了发展的底盘、巩固了发展的根基。 2025年，国内生产总值首次跃上140万亿元新台阶，比上年增长5%；城镇调查失业率平均值为5.2%，就 业保持总体稳定；货物贸易再创新高，外汇储备余额超过3.3万亿美元。 "进"的步伐更加有力。我国始终坚定不移走高质量发展道路，经济呈现向优向好发展势头。经济结构调 整优化，2025年规模以上高技术制造业增加值占规模以上工业增加值比重升至17.1%，最终消费支出对 经济增长贡献率超过五成。改革开放持续深化，全国统一大市场建设纵深推进，民营经 ...

数据显示，目前，我国规模以上机构以约15%的数量占比贡献了全行业超80%的营收，行业集约化发展 特征更加明显。市场监管总局表示，将坚持有效市场和有为政府相结合，通过市场化手段加速淘汰"小 散弱"机构，严格准入门槛从源头保障机构质量，推动资源要素向新能源、新材料、低空经济等战略性 新兴产业领域倾斜，提升国家级平台的含金量。 （来源：经济参考报） 1月19日，记者从市场监管总局获悉，我国检验检测机构现已确立"量减质升"的发展趋势。实施"有进有 出"的动态管理。启动"国家质检中心提质优化三年行动"，推动国家质检中心"瘦身"提质，资源要素向 战略性新兴产业领域倾斜。 打造区域创新高地。推动京津冀、长三角、珠三角等区域的技术共建与资源共享，形成跨区域的检验检 测服务集群，为区域经济高质量发展打造"增长极"。 市场监管总局提出，2026年，将以深化供给侧结构性改革为重点，加快构建与现代化产业体系相适配的 检验检测产业布局。 强化产业链协同创新。改变传统单打独斗模式，重点推进"质量强链"工程。聚焦"专业芯片"及"人工智 能+脑机接口"等前沿领域，组织国家质检中心与产业链上下游企业协同攻关，解决共性技术难题，为 新质生产力发 ...